From FLCCC ALLIANCE
A growing evidence base of dozens of studies around the world demonstrates ivermectin’s unique and highly potent ability to inhibit SARS-CoV-2 replication and aid in recovery from COVID-19. Based on this evidence, and on first-hand clinical observations, the FLCCC recommends its use, as part of a combination therapy, in all stages of COVID-19. View our protocols for more information on specific strategies.
